Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models. (Q50893682)

24 March 2018

title

Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models. (English)

1 reference

24 March 2018

0 references

Ying Zhao

1

1 reference

24 March 2018

Bo Huang

2

1 reference

24 March 2018

Shiguang Huang

3

1 reference

24 March 2018

Huanqin Zheng

4

1 reference

24 March 2018

Yun-quan Li

5

1 reference

24 March 2018

Zhao-rong Lun

6

1 reference

24 March 2018

Jilong Shen

7

1 reference

24 March 2018

Yong Wang

8

1 reference

24 March 2018

Lloyd H Kasper

9

1 reference

24 March 2018

Fangli Lu

10

1 reference

24 March 2018

publication date

20 June 2013

1 reference

24 March 2018

published in

Parasitology Research

1 reference

24 March 2018

volume

112

1 reference

24 March 2018

issue

9

1 reference

24 March 2018

page(s)

3151-3160

1 reference

24 March 2018

https://scigraph.springernature.com/pub.10.1007/s00436-013-3491-3

exact match

0 references

cites work

CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

MIF participates in Toxoplasma gondii-induced pathology following oral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

200 Gy sterilised Toxoplasma gondii tachyzoites maintain metabolic functions and mammalian cell invasion, eliciting cellular immunity and cytokine response similar to natural infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Veterinary vaccines against Toxoplasma gondii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Th1/Th2 cytokines' expression and production by propolis-treated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Role of gamma interferon in Toxoplasma gondii infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Evaluation of the adjuvant properties of Astragalus membranaceus and Scutellaria baicalensis GEORGI in the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

S100A8 modulates mast cell function and suppresses eosinophil migration in acute asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3491-3

Gene therapy for infectious diseases

21 January 2018

1 reference

12 December 2020

Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

1 reference

12 December 2020

Response of white mice to inoculation of irradiated organisms of theToxoplasma strain RH

1 reference

12 December 2020

Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine

1 reference

12 December 2020

Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection

1 reference

12 December 2020

Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death

1 reference

12 December 2020

Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.

1 reference

12 December 2020

Pidotimod in the management of vulvar papillomatosis: double-blind clinical trial versus placebo

1 reference

12 December 2020

Evaluation of the efficacy of pidotimod in the exacerbations in patients affected with chronic bronchitis

1 reference

12 December 2020

Pidotimod: a reappraisal.

1 reference

12 December 2020

Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice

1 reference

12 December 2020

Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN

1 reference

12 December 2020

The temperature-sensitive mutants of Toxoplasma gondii and ocular toxoplasmosis

1 reference

12 December 2020

Experimental immunological screening tests on pidotimod

1 reference

12 December 2020

Immune response to Toxoplasma gondii.

1 reference

12 December 2020

The prevalence and source of Toxoplasma infection in the environment

1 reference

12 December 2020

Microsatellite analysis in two populations of Kunming mice

1 reference

12 December 2020

Ex vivo evaluation of pidotimod activity in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Complementary treatment with oral pidotimod plus vitamin C after laser vaporization for female genital warts: a prospective study

1 reference

12 December 2020

10.1007/S00436-013-3491-3

Identifiers

DOI

1 reference

24 March 2018

PubMed ID

23783399

1 reference

24 March 2018